Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-08-034957
Filing Date
2008-06-13
Accepted
2008-06-12 18:01:09
Documents
6
Period of Report
2008-06-12

Document Format Files

Seq Description Document Type Size
1 v117192_6k.htm 6-K 21887
2 v117192_ex99-1.htm EX-99.1 11363
3 GRAPHIC logo.jpg GRAPHIC 10206
4 v117192_ex99-2.htm EX-99.2 81331
5 v117192_ex99-3.htm EX-99.3 37606
6 v117192_ex99-4.htm EX-99.4 5611
  Complete submission text file 0001144204-08-034957.txt   173381
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 08896712
SIC: 2834 Pharmaceutical Preparations